Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Farrelly

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Biomedical Engineering Education|August 22, 2025
Evaluating How Exposure to Scientific Role Models and Work-Based Microbadging Influences STEM Career Mindsets in Underrepresented GroupsDuncan Davis-Hall, Laura Farrelly, Melissa Risteff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 24, 2013
Roadmap for the European Network of Gynaecological Trial groups (ENGOT) TrialsIgnace Vergote, Gabriele Elser, Benedicte Votan, et al.
Plos One|March 23, 2023
A three protein signature fails to externally validate as a biomarker to predict surgical outcome in high-grade epithelial ovarian cancerAmy Hawarden, Marcus Price, Bryn Russell, et al.
Antiviral Therapy|May 4, 2005
Plasma pharmacokinetics of once- versus twice-daily lamivudine and abacavir: simplification of combination treatment in HIV-1-infected children (PENTA-13)Alina Bergshoeff, David Burger, Corrien Verweij, et al.
Clinical Trials (London, England)|July 27, 2019
Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization applicationAndrew Embleton-Thirsk, Elizabeth Deane, Stephen Townsend, et al.
The Pediatric Infectious Disease Journal|May 30, 2006
Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected childrenMarthe LePrevost, Hannah Green, Jacquie Flynn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
Ganetespib in Combination with Pemetrexed-Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib TrialDean A Fennell, Sarah Danson, Penella J Woll, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 24, 2020
ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapyOsnat Elyashiv, Jonathan Ledermann, Gita Parmar, et al.
JAMA Oncology|February 6, 2025
Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical TrialRebecca Kristeleit, Michael-John Devlin, Andrew Clamp, et al.
Thorax|November 25, 2022
Growing small solid nodules in lung cancer screening: safety and efficacy of a 200 mm<sup>3</sup> minimum size threshold for multidisciplinary team referralAndrew W Creamer, Carolyn Horst, Jennifer L Dickson, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Biomedical Engineering Education|August 22, 2025
Evaluating How Exposure to Scientific Role Models and Work-Based Microbadging Influences STEM Career Mindsets in Underrepresented GroupsDuncan Davis-Hall, Laura Farrelly, Melissa Risteff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 24, 2013
Roadmap for the European Network of Gynaecological Trial groups (ENGOT) TrialsIgnace Vergote, Gabriele Elser, Benedicte Votan, et al.
Plos One|March 23, 2023
A three protein signature fails to externally validate as a biomarker to predict surgical outcome in high-grade epithelial ovarian cancerAmy Hawarden, Marcus Price, Bryn Russell, et al.
Antiviral Therapy|May 4, 2005
Plasma pharmacokinetics of once- versus twice-daily lamivudine and abacavir: simplification of combination treatment in HIV-1-infected children (PENTA-13)Alina Bergshoeff, David Burger, Corrien Verweij, et al.
Clinical Trials (London, England)|July 27, 2019
Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization applicationAndrew Embleton-Thirsk, Elizabeth Deane, Stephen Townsend, et al.
The Pediatric Infectious Disease Journal|May 30, 2006
Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected childrenMarthe LePrevost, Hannah Green, Jacquie Flynn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
Ganetespib in Combination with Pemetrexed-Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib TrialDean A Fennell, Sarah Danson, Penella J Woll, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 24, 2020
ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapyOsnat Elyashiv, Jonathan Ledermann, Gita Parmar, et al.
JAMA Oncology|February 6, 2025
Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical TrialRebecca Kristeleit, Michael-John Devlin, Andrew Clamp, et al.
Thorax|November 25, 2022
Growing small solid nodules in lung cancer screening: safety and efficacy of a 200 mm<sup>3</sup> minimum size threshold for multidisciplinary team referralAndrew W Creamer, Carolyn Horst, Jennifer L Dickson, et al.
Pageof 4